About U-Ploid Biotechnologies
U-Ploid Biotechnologies is a company based in London (United Kingdom) founded in 2024 by Alexandre Webster and Jordan Abdi. It operates as a B2B. U-Ploid Biotechnologies offers products and services including IVF Therapeutics. U-Ploid Biotechnologies operates in a competitive market with competitors including AIVF, Seragen, IVF, BAIBYS and Proiser, among others.
- Headquarter London, United Kingdom
- Founders Alexandre Webster, Jordan Abdi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of U-Ploid Biotechnologies
U-Ploid Biotechnologies offers a comprehensive portfolio of products and services, including IVF Therapeutics.
Develops treatments to improve aged egg quality for enhanced IVF success.
Funding Insights of U-Ploid Biotechnologies
Detailed funding history for U-Ploid Biotechnologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by U-Ploid Biotechnologies
Investment portfolio details for U-Ploid Biotechnologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - U-Ploid Biotechnologies
Detailed financials for U-Ploid Biotechnologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
U-Ploid Biotechnologies Comparisons
Peer comparison for U-Ploid Biotechnologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of U-Ploid Biotechnologies
U-Ploid Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIVF, Seragen, IVF, BAIBYS and Proiser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based platform for analyzing embryos in IVF treatments is provided.
|
|
| Locked | Locked | Locked |
Point-of-care therapeutics and AI platform are offered for infertility treatment.
|
|
| Locked | Locked | Locked |
Provider of AI based decision-making tools for IVF professionals
|
|
| Locked | Locked | Locked |
AI-based sperm selection is provided to healthcare providers.
|
|
| Locked | Locked | Locked |
It develops automated semen analysis and diagnostic systems
|
Detailed competitors of U-Ploid Biotechnologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on U-Ploid Biotechnologies
Complete news archive for U-Ploid Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about U-Ploid Biotechnologies
U-Ploid Biotechnologies was founded in 2024.
U-Ploid Biotechnologies is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jordan Abdi is the current CEO of U-Ploid Biotechnologies. They have also founded this company.
U-Ploid Biotechnologies focuses on creating innovative treatments to restore fertility in aged eggs by improving their quality and integrating seamlessly with existing IVF protocols. Based in Cambridge, UK, the company collaborates with clinics and research organizations worldwide to enhance outcomes for women facing age-related infertility. Their work aims to reduce the need for multiple IVF cycles, making treatments more accessible and effective through scalable solutions.
U-Ploid Biotechnologies offers IVF Therapeutics.